Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a prospective, single-arm phase II study
收藏integrated proteome resources2026-02-07 收录
下载链接：
https://www.iprox.cn/page/project.html?id=IPX0013911000
下载链接
链接失效反馈官方服务：
资源简介：
Anti-PD-1 plus nab-paclitaxel and bevacizumab for second-line treatment of cancer of unknown primary (Fudan CUP-002): a prospective, single-arm phase II study
提供机构：
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University
创建时间：
2025-10-24
